- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 263251-78-1] Tavilermide
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-17622 |
| Brand: | MCE |
| CAS: | 263251-78-1 |
Overview
| MDL | - |
|---|---|
| Molecular Weight | 580.54 |
| Molecular Formula | C24H32N6O11 |
| SMILES | O=C(O)CC[C@H](N1)C(N[C@@H](CCCCN)C(N[C@H](C(NCC(O)=O)=O)CCOC2=CC=C([N+]([O-])=O)C=C2C1=O)=O)=O |
2 Publications Citing Use of MCE
Summary
Tavilermide is a selective, partial agonist of TrkA , or a nerve growth factor (NGF) mimetic.
IC50 & Target
TrkA [1]
In Vitro
Tavilermide (MIM-D3) is a tyrosine kinase TrkA receptor agonist, which can be used to treat dry eye.Tavilermide is a proteolytically stable, cyclic peptidomimetic that has been shown to be a partial TrkA receptor agonist. Tavilermide demonstrates activities similar to NGF (but does not bind to the p75NTR receptor) and can potentiate the effects of suboptimal concentrations of NGF [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT01257607 | Mimetogen Pharmaceuticals USA, Inc. |
Dry Eye
|
November 2010 | Phase 2 |
| NCT02665234 | Mimetogen Pharmaceuticals USA, Inc. |
Keratoconjunctivitis Sicca
|
January 2016 | Phase 3 |
| NCT03925727 | Mimetogen Pharmaceuticals USA, Inc. |
Keratoconjunctivitis Sicca|Dry Eye
|
March 28, 2019 | Phase 3 |
| NCT01960010 | Mimetogen Pharmaceuticals USA, Inc. |
Dry Eye Syndromes
|
October 2013 | Phase 3 |
| NCT02634853 | Mimetogen Pharmaceuticals USA, Inc. |
Keratoconjunctivitis Sicca
|
December 2015 | Phase 3 |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
NH4OH : 50 mg/mL ( 86.13 mM ; ultrasonic and adjust pH to 10 with NH4OH)
H 2 O : 2 mg/mL ( 3.45 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 1.7225 mL | 8.6127 mL | 17.2253 mL |
| 5 mM | 0.3445 mL | 1.7225 mL | 3.4451 mL |
| 10 mM | 0.1723 mL | 0.8613 mL | 1.7225 mL |
-
1.
Add each solvent one by one: 50% PEG300 >> 50% saline
Solubility: 25 mg/mL (43.06 mM); Suspended solution; Need ultrasonic
-
2.
Add each solvent one by one: 0.5% CMC-Na /saline water
Solubility: 10 mg/mL (17.23 mM); Suspended solution; Need ultrasonic
-
3.
Add each solvent one by one: PBS
Solubility: 4.17 mg/mL (7.18 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.